Company: REVB
Filing Date: 2025-04-04
Form Type: DRS
Source: 0001213900-25-029022
Chunk: 154

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-04-04
Form: DRS
Chunk 154
---
 exercise price of $16.00 per share of common stock, is exercisable at any time after January 17, 2025, will expire on January 17, 2027 and is subject to customary adjustments. Each Class F Common Stock Warrant can be exercised 2shares of common stock per Class F Common Stock Warrant in an alternative cashless exercise. The Class F Common Stock Warrants may not be exercised if the aggregate number of shares of the Company’s common stock beneficially owned by the holder (together with its affiliates) would exceed 4.99% of the Company’s outstanding common stock immediately after exercise. However, the holder may increase (upon 61 days’ prior notice from the holder to the Company) or decrease such percentage, provided that in no event such percentage exceeds 9.99%. Class G Common Stock Warrants There are 1,621,463 Class G Common Stock Warrants issued and outstanding as of the date of this Prospectus. Each Class G Common Stock Warrant has an exercise price of $3.76 per share of common stock, is exercisable at any time after January 17, 2025, will expire on January 17, 2030 and is subject to customary adjustments. The Class G Common Stock Warrants may not be exercised if the aggregate number of shares of the Company’s common stock beneficially owned by the holder (together with its affiliates) would exceed 4.99% of the Company’s outstanding common stock immediately after exercise. However, the holder may increase (upon 61 days’ prior notice from the holder to the Company) or decrease such percentage, provided that in no event such percentage exceeds 9.99%. Public Warrants There are currently outstanding an aggregate of 10,511,597 Public Warrants, which entitle the holder to acquire shares of Common Stock. Each whole Public Warrant will entitle the registered holder to purchase 1/1,050 of a share of common stock at a price of $12,075.00 per share, subject to adjustment as discussed below, beginning 30 days after 100 the closing of the Business Combination, provided that Revelation has an effective registration statement under the Securities Act covering the shares of Common Stock issuable upon exercise of the warrants and a current prospectus relating to them is available (or it permits holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement) and such shares are registered, qualified or exempt from registration under the securities, or